AstraZeneca CFO Aradhana Sarin tells Yahoo Finance the company sees US innovation threatened by China, even as it commits $50 billion in manufacturing.

The UK’s largest listed companies are turning their heads towards the glimmer of the Nasdaq after growing impatient ...

AstraZeneca has announced a jump in sales in recent months after a surge in demand for cancer drugs, as the pharmaceutical ...

Speaking from Astra's offices in New York, Sir Pascal Soriot (pictured) said it was 'global', but it was 'very much rooted ...

Cambridge headquartered AstraZeneca saw its UK share price rocket 328p to 11,118 and its market cap soar to £173.49 billion after a stunning set of results for the first half and second quarter of ...

Uncertainty about pharmaceutical tariffs continues to loom over the pharmaceutical industry, with some companies committing ...

With its latest $50 billion U.S. manufacturing investment and record U.S. growth, is British AstraZeneca looking at itself as ...

Despite the EU and US agreeing a basic trade deal on Monday, the FTSE 100 and some European stocks fell on the day after a ...

Soriot said the industry should help shape pricing reforms before they are imposed by regulators, and backed applying changes ...

A formal trade agreement between the US and EU introduces a 15% tariff on most EU exports, including pharmaceuticals, ...

While value has outperformed growth in Europe over the past five years, Europe now represents less than half of equity market ...